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Background: This study aims to investigate the role of OX40 ligand (OX40L) in ocular inflammation via abrogation
of retinal pigment epithelium (RPE)-mediated immunosuppression using an in vitro expression approach. OX40L
cDNA was polymerase chain reaction-amplified and cloned into an eYFP fusion vector. Cultured retinal pigment
epithelial cells (ARPE-19) were transfected with the vector. Total RNA from unstimulated or inflammatory
cytokine-stimulated ARPE cells were isolated and analyzed for OX40L expression by reverse transcription-polymerase
chain reaction. Peripheral blood mononuclear cells (PBMCs) were isolated from healthy human donors. Human
ARPE cells (±OX40L ± GITR ligand (GITRL) expression) and PBMCs were co-cultured for in vitro proliferation studies.
Results: Polymerase chain reaction confirmed the insertion of the OX40L gene into the fusion vector. Flow
cytometry and fluorescence microscopy further confirmed surface expression of OX40L on ARPE cells after
transfection. OX40L expression was induced in the RPE cells stimulated with pro-inflammatory cytokines. In the
co-culture studies, there was a significant reversal (20% to 30%) of the RPE-induced suppression of activated PBMCs
when the ARPE cells were transfected with OX40L. When both OX40L and GITRL were concomitantly transfected
into ARPE cells, there was an additive reversal of RPE-mediated T cell suppression, when compared to the reversal
caused by RPE cells expressing either OX40L alone or GITRL alone.
Conclusions: Using an in vitro approach, we found that OX40L causes an abrogation of the RPE-mediated
immunosuppression. OX40L appears to be regulated in the ARPE-19 cell line and may play an important role in the
pathogenesis of various ocular inflammatory conditions.
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OX40 ligand (OX40L) is a member within the TNF lig-
and superfamily [1-4] and plays an important role in the
induction of co-stimulatory signaling during T cell and
antigen-presenting cell (APC) interactions [5-9]. Prior
studies have demonstrated that OX40L is expressed pre-
dominantly on CD4+ T cells [10,11]. In addition to its
role in co-stimulatory signaling, OX40/OX40L inter-
action is closely involved in effector functions [12-15].
OX40L expression has been observed on APCs includ-
ing dendritic cells [16,17], B cells [12], and microglial* Correspondence: macunning@gmail.com
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reproduction in any medium, provided the origcells [18], but has also been found on non-lymphoid
cells (i.e., endothelial cells) [19].
Recently, its potential role in the pathogenesis of
immune-mediated ophthalmic diseases including uveitis,
experimental allergic conjunctivitis, and corneal graft re-
jection has been investigated [20-23]. A recent study by
Zhang et al. described the activation of ovalbumin-specific
T cells with OX40-activating antibody and found that
OX40-stimulated lymphocytes elicited more ocular in-
flammation compared to donor cells without OX40 activa-
tion. Moreover, flow cytometry showed that Th17 cells
expressed OX40 ligand, and interleukin-17 neutralizing
antibody was successful in the attenuation of OX40-
mediated uveitis [22]. In another study of experimental
autoimmune uveitis, OX40 activation was found to pro-
mote the expansion uveitogenic memory T cells, ashis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 OX40L gene identification by PCR. PCR performed on
purified plasmid with and without OX40L insert. Note the
presence of OX40L in lanes 7 and 9. (Lane 6, low range DNA
ladder; lane 7, eYFP-C1 + OX40L insert; lane 8, eYFP-C1 plasmid;
lane 9, eYFP-N1 +OX40L insert; lane 10, eYFP-N1 plasmid).
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lymphocytes [23].
Other animal models of ocular inflammation have
been described. In a murine model of experimental aller-
gic conjunctivitis, in vivo stimulation of OX40 with an
anti-OX40 antibody led to the exacerbation of ocular
surface inflammatory disease, while antibody blockade of
the OX40/OX40L interaction inhibited disease expres-
sion [20]. Hattori et al. characterized OX40/OX40L
interaction in a murine model of corneal transplant re-
jection. They describe significantly reduced corneal allo-
graft rejection in mice treated with a monoclonal
antibody targeting murine OX40L when compared to
control mice. In addition, OX40 ligand-deficient mice
demonstrated a decreased risk of allograft rejection
when transplanted with wild-type donor corneas. An
in vitro study also revealed that treatment with anti-
OX40L monoclonal antibody reduced the proliferative
response and interferon-gamma production of lymph
node cells after donor alloantigen stimulation. These stud-
ies were suggestive that OX40L blockade prolonged graft
survival via inhibition of recipient T cell activation [21].
Thus, while OX40L and OX40 in activating inflamma-
tion has been suggested by several animal models of sys-
temic and ophthalmic inflammation, the precise pathways
by which OX40L leads to these ocular inflammatory se-
quelae warrants further investigation. The eye is an
immune-privileged organ, and multiple mechanisms are
thought to contribute to this privilege [24-26] including
retinal pigment epithelium (RPE)-mediated suppression of
T cell activation [27], induction of apoptosis of activated T
cells via Fas-FasL interactions [28], and inhibition of T cell
proliferation by a cell-contact-dependent mechanism [29].
Using an in vitro expression system previously described
in a report for GITR ligand [30], another important mem-
ber of the TNF superfamily, we sought to further investi-
gate the role of OX40L and its role in ocular
inflammation, specifically in its ability to abrogate RPE-
mediated immunosuppression. We found that OX40L
causes abrogation of RPE-mediated immunosuppression
and appears to be regulated within RPE cells.
Results
Confirmation of OX40L insertion into eYFP vector
To confirm the correct insertion of the OX40L gene into
the eYFP vector, polymerase chain reaction (PCR) was
performed on the purified products. OX40L was detected
using PCR (Figure 1), along with restriction enzyme
(BamH1 and HindIII) overnight digestion. The gene was
identified in both the eYFP-C1 and eYFP-N1 vectors.
Expression of OX40L on ARPE-19 cells
Using flow cytometry and a biotinylated anti-OX40L
antibody, we found that the expression of OX40L wasundetectable (data not shown). After transfection,
OX40L was expressed on RPE cells, and the expression
was monitored using both flow cytometry and fluores-
cence microscopy.
In a time and dosage trial, after verified transfection of
the eYFP-OX40L construct into RPE cells, surface expres-
sion of OX40L was demonstrated as early as 4 h after
transfection (see Figure 2). The expression of our protein
was primarily cytosolic prior to the 4-h mark. This was
Figure 2 Time trial after vector transfection. (a) Bar graph representing the expression pattern of the fluorescent protein (YFP) and OX40L after
transfection of eYFP-C1-OX40L into RPE at five time points (time point 1 = 30 min, time point 2 = 1 h, time point 3 = 4 h, time point 4 = 6 h, and time
point 5 = 24 h). Time-dependent increased expression is observed. (b) Flow cytometric analysis at 4 h after transfection of RPE cells with eYFP-C1-
OX40L, with YFP expression (bold) in the left panel and OX40L expression (bold) in the right panel (the thinner lines represent RPE that was not
transfected). (c) Bar graph expression pattern of YFP and OX40L after transfection of eYFP-N1-OX40L into RPE cells at the same time points. (d) Flow
cytometric analysis at 4 h after transfection of RPE cells with eYFP-N1-OX40L.
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eYFP fluorescent protein as early as 30 min after transfec-
tion. During the dosage trial, transfecting a dose of 0.5 μg
per 0.6 × 106 RPE cells led to an expression >90% (data
not shown). Larger transfection dosages led to a plateau
effect, and dosages >5 μg, in the eYFP-OX40L-C1 con-
struct, had a toxic effect to the RPE cells (data not shown).
Cytokine-mediated regulation of OX40L RNA in cultured RPE
Using reverse transcription-polymerase chain reaction
(RT-PCR), the OX40L RNA content in resting, unstimu-
lated RPE cells and in RPE cells stimulated for 24 h with
high levels of the pro-inflammatory cytokines IL-1α,
TNF-α, and IFN-γ were compared. Constitutive expres-
sion of OX40L RNA was not observed in unstimulated
RPE cells; however, in the stimulated RPE cells, OX40L
was expressed (Figure 3).
Transient expression of OX40L in RPE cell reverse
RPE-induced suppression of PBMCs
A co-culture of RPE cells (with or without OX40L ex-
pression) and PBMCs (with or without anti-CD3/anti-CD28 stimulation) was performed. RPE cells without
OX40L expression, when co-cultured with either stimu-
lated or unstimulated PBMCs, demonstrated the greatest
suppressive activity (Figure 4). When RPE cells were
transfected with either the eYFP-C1-OX40L or the
eYFP-N1-OX40L construct, an approximately 20% to
30% reversal of the RPE-mediated suppression of
PBMCs was observed. A significant difference in the ab-
rogation of RPE-mediated suppression was not observed
between the RPE transfected with the eYFP-N1-OX40L
and the eYFP-C1-OX40L vectors. Interestingly, when
both OX40L-C and GITR ligand (GITRL) were trans-
fected into RPE cells, an increase in the reversal of RPE-
mediated suppression was observed when compared to
the reversal demonstrated with RPE transfected with
OX40L-C or GITRL alone (data not shown).
Discussion
A significant body of evidence has supported the role of
RPE cells in the maintenance of ocular immune privilege
[27,31-33]. RPE cells are capable of acting as efficient
APCs expressing MHC class II molecules, and exposure
Figure 3 RT-PCR demonstrated expression of OX40L in the RNA
of ARPE cells stimulated by pro-inflammatory cytokines. Lanes 1
and 2 are two different DNA ladders; lanes 3 and 4 represent two
different concentrations of the same RNA from stimulated RPE cells.
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cell activation or T cell regulation [31,34].
A number of the TNF receptor family members are
thought to promote inflammatory processes via T cell
co-stimulation, proliferation, and differentiation. The
TNF-R/TNF-α interaction has been well described both
in experimental animal models and patients with ocular
inflammatory diseases. We previously showed that an-
other member of the TNF receptor family, GITRL, may
also play a role in ocular inflammation. Specifically,
GITRL expression was able to abrogate the immunosup-
pressive function of RPE cells on CD3+ T cells via
decreased TGF-beta expression in RPE/CD3+ T cell co-
cultures and increased production of pro-inflammatory
cytokines and chemokines [30]. In patients with uveitis,
GITR was found to be an activation marker for CD4+ T
cells and was co-expressed with CD25 on CD4+ T cells
in peripheral blood. The presence of GITR was also
found to be correlated with disease course in uveitis
[35].In this study, we investigated whether OX40L, another
member of the TNF family involved with inflammatory
disease states, may play a role in the pathogenesis of
ocular inflammation. However, current human RPE cell
lines do not express OX40L at the protein level. More-
over, in unactivated human RPE cells, we did not ob-
serve OX40L at the RNA level. Nonetheless, after
exposure of RPE cells to a pro-inflammatory cytokine
milieu (IL-1α,TNF-α, and IFN-γ), we did observe OX40L
RNA expression. This represents the first demonstration
of OX40L RNA in ocular tissue and suggests that
OX40L expression is an inducible phenomenon in the
setting of localized inflammation.
To investigate the functional role of OX40L in RPE
cells, we used an in vitro expression approach to mimic
a pro-inflammatory environment. The use of a
fluorescent-tagged fusion vector allowed us to confirm
the presence of OX40L transfection into RPE cells and
its expression using flow cytometry. In RPE-PBMC co-
culture experiments, we found that RPE cells expressing
OX40L (after transfection) reversed the immunosup-
pression afforded by RPE cells that did not express
OX40L. PBMCs rather than purified T cells were used to
simulate an extracellular milieu that would more closely
mimic the ocular immune environment in vivo. OX40L
was transfected in ARPE cells, which normally do not
express OX40L, to mimic the ocular inflammatory
scenario.
Recent reports have shown that the OX40-OX40L
interaction may play a role in a number of ocular in-
flammatory processes including corneal transplant rejec-
tion [21], experimental allergic conjunctivitis [20],
herpes stromal keratitis [36], and uveitis. Several recent
studies have described the relationship of OX40 ligand
in the exacerbation and prolongation of animal models
of uveitis as well as its role in augmenting the pro-
inflammatory Th17 cytokine response.
Moreover, several other mechanisms by which OX40L
perpetuates the inflammatory process in other biologic
systems have been suggested. OX40L was recently found
to inhibit the generation of IL-10 producing CD4+ type
1 regulatory T cells from naive T cells. In addition,
OX40L inhibited IL-10 production in differentiated IL-
10 producing regulatory T cells [37]. Other proposed
functions of OX40L include its role in the T cell effector
response, T cell-APC co-stimulatory signaling, the T cell-
dependent humoral responses [38], and the promotion
of CD4+ T cell longevity [39].
Conclusions
The numerous mechanisms by which OX40L may acti-
vate inflammation or abrogate immunosuppression, par-
ticularly in the complex ocular immune environment in
which immune privilege is critical to immunoregulation,
Figure 4 ARPE-19 and PBMC co-culture study results. (a) OX40L-C + PBMC abrogates the immunosuppressive effect of RPE alone. No
difference was observed between OX40L (C- or N- vectors) or GITR ligand. An approximately 20% to 30% reversal of RPE-mediated
immunosuppression is seen when stimulated pBMCs were co-cultured with RPE-OX40L vector. (b)A repeat experiment shows that concomitant
transfection of both eYFP-C1-OX40L and eYFP-C1-GITRL vectors into RPE cells resulted into an additive reversal of immunosuppression of
stimulated pBMCs, when comparing it to either RPE transfected with OX40L-C or GITRL alone. (pBMC unstim, unstimulated peripheral blood
mononuclear cells; pBMC stim, stimulated pBMC with anti-CD3 and anti-CD28; RPE, retinal pigment epithelial cells without transfection; OX40L-C,
RPE cells transfected with eYFP-C1-OX40L; OX40L-N, RPE cells transfected with eYFP-N1-OX40L; GITRL, RPE cells transfected with eYFP-C1-GITRL).
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that a pro-inflammatory cytokine milieu is sufficient to
induce RNA expression of OX40L by RPE cells, and its
expression appears to be highly regulated. In addition,
our co-culture experiments with activated PBMCs and
transfected RPE cells demonstrate that OX40L expres-
sion is associated with dampening of RPE-mediated im-
munosuppression, a novel finding that warrants
additional investigation. This study, along with prior
work on the role of GITRL in ocular inflammation, adds
to the growing evidence that other members of the TNF
ligand superfamily besides TNF-α may play a role in
ocular immunity. Further studies will be needed to de-
termine the precise role of OX40L in human uveitis and
whether modulation of OX40L pathways may have
therapeutic implications.Methods
Reagents, cell lines, and antibodies
The retinal pigment epithelial cells (ARPE-19 cells) were
originally obtained from ATCC (Manassas, VA, USA)
and were cultured in minimum essential medium
(MEM) with 10% fetal bovine serum (FBS; Gemini Bio-
products, West Sacramento, CA, USA), 1X nonessential
amino acids, 1X antibiotics, and 2 mM glutamine (Bio-
source International, Bethesda, MD, USA) at 37°C in 5%
CO2. Biotinylated polyclonal goat anti-human OX40L
antibody (Catalog # BAF1054) was obtained from R & D
systems (Minneapolis, MN, USA). IL-1α, TNF-α, and
IFN-γ were purchased from Biosource International
(Camarillo, CA, USA). The media and FBS were pur-
chased as lipopolysaccharide-free-grade reagents.Plasmid
The fusion vectors eYFP-C1 and eYFP-N1 (BD Bios-
ciences Clontech, San Jose, CA, USA) were used so
that we could readily assess the presence of stably
inserted OX40L DNA. The eYFP-C1 vector attaches
the tag protein eYFP to the C-terminal (intracellular)
region of the inserted gene, while the eYFP-N1 vector
attaches eYFP protein to the N-terminal (extracellu-
lar) region of the inserted gene.
Cloning of full-length hOX40L cDNA
Full-length OX40L was amplified from a human HTLV-
1-infected T cell lymphoma (MT-2) cell line [40] using
hOX40L specific primers:










RT-PCR was performed with the one-step RT-PCR kit
(Promega, Madison, WI, USA) according to the manu-
facturer's instructions. The amplification procedure for
RT-PCR was as follows: 48°C for 75 min, 94°C for 2
min and 30 s followed by cycles of the following: 94°C for
30 s, 50°C for 45 s, and 72°C for 1 min. There was a total
of 40 cycles.
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the QIAquick PCR purification kit (Qiagen Inc., Santa
Clarita, CA, USA), and full-length OX40L was subcloned
in frame into either the eYFP-C1 or eYFP-N1 vector. With
eYFP-C1, the gene was inserted between the eYFP coding
sequence and the stop codon, and with eYFP-N1, the
OX40L gene was inserted between the immediate early
promoter of CMV and the eYFP coding sequence.
Transfection of ARPE-19 cell line
To facilitate the expression of hOX40L in RPE cells,
human adult retinal pigment epithelial cell line ARPE-19
was transfected with the construct eYFP-C1-OX40L or
with eYFP-N1-OX40L using the Nucleofector transfection
system (Amaxa Inc, Gaithersburg, MD, USA). Prior to
transfection, RPE cells were grown to 80% to 85% conflu-
ence and resuspended in 2 to 3× 106 cells/0.1 mL Nucleo-
fector Solution V with 2 μg of eYFP-OX40L construct.
The solution was transferred to a sterile electroporation
cuvette and transfected using program #T20 according to
manufacturers’ instructions. The transfected cells were
then plated in the culture medium (MEM, 10% FBS, 1X
antibiotics) on six-well culture plates.
Expression of OX40L
Flow cytometry was utilized to analyze the surface ex-
pression of OX40L in RPE cells and to study the OX40L
expression patterns in a time trial and at varying trans-
fection dosages. For the time trial, RPE cells (2 × 106
cells) transfected with either eYFP-C1-OX40L or eYFP-
N1-OX40L for different time points (30 min, 1, 4, 6, and
24 hr) were incubated in cold PBS (pH 7.4) with 0.5%
BSA with or without biotinylated anti-OX40L antibody
for the detection of surface OX40L. Cells were washed
and fixed with 1% paraformaldehyde, counted via the
FACS Calibur flow cytometer (Becton Dickinson, San
Jose, CA, USA), and analyzed using FlowJo software
(TreeStar, San Jose, CA, USA). Total RNA from cultured
RPE cell lines was isolated with an RNA isolation kit
(RNeasy, Qiagen Inc.) using the manufacturers’ instruc-
tions. Prior to RNA isolation, one cell line was stimu-
lated for 24 h with 5.0 ng/mL of IL-1α,5.0 ng/mL of
TNF-α, and 25 ng/mL of IFN-γ. Another cultured cell
line was transfected with 1 μg eYFP-OX40L construct
and served as the positive control for the RT-PCR. The
last cultured cell line was not treated with pro-
inflammatory cytokines and represented resting RPE
cells. Using 1 μg of RNA, initially, RT-PCR was used to
screen for the product (OX40L). The amplification pro-
cedure was as follows: 48°C for 75 min, 94°C for 2 min
and 30 s followed by cycles of the following: 94°C for 30
s, 50°C for 45 s, and 72°C for 1 min. There was a total of
40 cycles. The primers used for amplification were from
different exons and their sequences were as follows:OX40L, 50-TCACCTACATCTGCCTGCACTTCTCTG
CTCTT-30 and 50-ATCAGTTCTCCGCCATTCACA-30.
Isolation of peripheral blood mononuclear cells
Human peripheral blood mononuclear cells (PBMCs)
were isolated from buffy coat obtained from normal,
healthy donors (NIH blood bank) using the Ficoll gradient
centrifugation.
RPE-PBMC co-culture studies
An RPE-PBMC co-culture system was used for the
in vitro proliferation studies. ARPE-19 cells were grown
to 80% to 85% confluence and transfected with eYFP-
OX40L vector. Twelve hours after transfection, the RPE
cells were lethally irradiated (9,000 rads), washed with
FBS-supplemented RPMI 1640 medium and plated in
96-well flat-bottomed culture plates, using enough RPE
cells to obtain complete confluence. Isolated PBMCs
(2 ×105cells/well) were co-cultured with the already pla-
ted RPE cells. To a set number of cultures, anti-CD28
antibody (2 μg/mL) and anti-CD3 antibody (2 μg/mL)
were added. After 3 days of culturing at 37°C in 5% CO2,
the cultures were pulsed with 3H thymidine (Amersham,
Buckinghamshire, UK) and then cultured for another 8
to 12 h. The cells were harvested, and uptake of 3H thy-
midine was measured by a beta counter (Perkin Elmer
Life Sciences, Waltham, MA, USA). The effect of RPE
cells (± transfected with OX40L) on PBMCs (± stimula-
tion) was expressed as delta counts per minute (Δcpm).
All experiments were performed in triplicate and sum-
marized herein.
All research conformed to the ARVO statement on
human and animal research and the Declaration of
Helsinki. Samples from normal donors were obtained
from the National Institutes of Health blood bank after
informed consent was obtained.
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